Canada markets closed

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.9400+0.9200 (+22.89%)
At close: 04:00PM EDT
5.1400 +0.20 (+4.05%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.12M
Enterprise Value 995.37k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.37
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.21

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-96.29%
S&P500 52-Week Change 323.49%
52 Week High 3141.7500
52 Week Low 33.9400
50-Day Moving Average 35.9959
200-Day Moving Average 320.3269

Share Statistics

Avg Vol (3 month) 3225.08k
Avg Vol (10 day) 377.32k
Shares Outstanding 5834.9k
Implied Shares Outstanding 6834.9k
Float 8823.54k
% Held by Insiders 10.75%
% Held by Institutions 11.37%
Shares Short (May 15, 2024) 414.85k
Short Ratio (May 15, 2024) 40.03
Short % of Float (May 15, 2024) 41.78%
Short % of Shares Outstanding (May 15, 2024) 41.78%
Shares Short (prior month Apr 15, 2024) 446.08k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Apr 26, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.58%
Return on Equity (ttm)-180.17%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.64M
Net Income Avi to Common (ttm)-105.53M
Diluted EPS (ttm)-958.3500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.03M
Total Cash Per Share (mrq)2.44
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.30
Book Value Per Share (mrq)13.44

Cash Flow Statement

Operating Cash Flow (ttm)-7.91M
Levered Free Cash Flow (ttm)-4.93M